Closed-Loop Insulin Delivery During Pregnancy (IADIABENCEINTE)
Launched by CENTRE HOSPITALIER SUD FRANCILIEN · Dec 13, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
Diabetes imbalance is associated with an increased risk of maternal and fetal complications, and achieving target blood glucose levels before and during pregnancy in women with type 1 diabetes (T1DM) significantly reduces these complications. In women, it can cause abortion, hypertension, pre-eclampsia, and dystocic deliveries; in the fetus, it increases the risk of numerous malformations, including neurological and cardiac, fetal death in utero, intrauterine growth retardation, macrosomia, prematurity, and metabolic complications at birth such as neonatal hypoglycemia and hypocalcemia.
Th...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • aged at least 18 years
- • had been diagnosed with type 1 diabetes before pregnancy
- • using an hybrid closed-loop insulin delivery system before or at any time of pregnancy
- Exclusion Criteria:
- • Patient opposed to the research
Trial Officials
Alfred PENFRONIS, PHD
Principal Investigator
Centre Hospitalier Sud Francilien
About Centre Hospitalier Sud Francilien
Centre Hospitalier Sud Francilien (CHSF) is a prominent healthcare institution located in the Île-de-France region, committed to advancing medical knowledge and improving patient care through innovative clinical research. As a sponsor of clinical trials, CHSF harnesses its state-of-the-art facilities and multidisciplinary expertise to conduct robust studies across various therapeutic areas. With a focus on patient safety and ethical standards, CHSF collaborates with leading researchers and healthcare professionals to explore new treatments and enhance clinical outcomes, ultimately contributing to the evolution of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Corbeil Essonnes, , France
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials